NCT02869217 2025-12-03Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid TumorsUniversity Health Network, TorontoPhase 1 Active not recruiting22 enrolled
NCT03618381 2025-11-20EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsSeattle Children's HospitalPhase 1 Active not recruiting44 enrolled
NCT04483778 2025-11-20B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsSeattle Children's HospitalPhase 1 Active not recruiting68 enrolled
NCT06644755 2025-07-24First-in-Human Trial of DS-2243a in Participants With Advanced Solid TumorsDaiichi SankyoPhase 1 Recruiting150 enrolled
NCT03132922 2024-01-22MAGE-A4ᶜ¹º³²T for Multi-TumorAdaptimmunePhase 1 Active not recruiting71 enrolled
NCT02457650 2016-08-03T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing MalignanciesShenzhen Second People's HospitalPhase 1 Unknown36 enrolled